Clinician
Resources

Todd Rosengart, M.D., F.A.C.S.

Professor and Chair, Department of Surgery
Baylor College of Medicine

Request Clinical Appointment

Positions

Professor and Chair, Department of Surgery
Baylor College of Medicine

DeBakey-Bard Chair of Surgery
Baylor College of Medicine

Professor of Molecular & Cellular Biology
Baylor College of Medicine

Professor of Heart and Vascular Disease
Texas Heart Institute

Address

Baylor Medicine at McNair Campus (Clinic)
7200 Cambridge Street
6th Floor
Houston, Texas 77030
United States
(713) 798-8504
Google Maps

Certifications

Board Certified American Board of Surgery
Board Certified American Board of Thoracic Surgery

Education

Clinical Fellowship at The New York Hospital
New York
Thoracic Surgery
Research Fellowship at National Institutes of Health
01/1987 - Bethesda, MD United States
Residency at New York University Medical Center
01/1989 - New York, New York United States
General Surgery
Internship at New York University Medical Center
01/1985 - New York, NY United States
General Surgery
MD from Northwestern University
01/1983 - Chicago, IL United States

Languages

English
Spanish

Gender

Male

Planning Committee

Vein Graft Disease: What Have We Learned about Making a Vein into an Artery?
Michael E. DeBakey Department of Surgery Grand Rounds
January 29, 2020

Minority MOMP: An Oncogenic Mechanism Or An Opportunity to Kill the Cancer Cell?
Michael E. DeBakey Department of Surgery Grand Rounds
February 12, 2020

Adolescent Metabolic and Bariatric Surgery
Michael E. DeBakey Department of Surgery Grand Rounds
February 19, 2020

Surgical Coaching for Continuous Performance Improvement
Michael E. DeBakey Department of Surgery Grand Rounds
February 26, 2020

In the Time of Covid-19: What We Should Know?
Michael E. DeBakey Department of Surgery Grand Rounds
April 8, 2020

We Are Not Bullies, Are We? Diversity, Inclusion, Unconscious Bias, and Microaggression
Michael E. DeBakey Department of Surgery Grand Rounds
April 22, 2020

Gender Equality in Surgery and Surgical Training
Michael E. DeBakey Department of Surgery Grand Rounds
April 29, 2020

Chief Resident Presentations 2020, Part 1
Michael E. DeBakey Department of Surgery Grand Rounds
May 6, 2020

Chief Resident Presentations 2020, Part 2
Michael E. DeBakey Department of Surgery Grand Rounds
May 13, 2020

Chief Resident Presentations 2020, Part 3
Michael E. DeBakey Department of Surgery Grand Rounds
May 20, 2020

Debunking Myths in Bariatric Surgery
Michael E. DeBakey Department of Surgery Grand Rounds
September 9, 2020

Surgical Innovation and Life-Long Learning: The Case of the Esophagus
Michael E. DeBakey Department of Surgery Grand Rounds
September 30, 2020

Controversies in Surgical Thyroidology in 2020
Michael E. DeBakey Department of Surgery Grand Rounds
October 14, 2020

The Elegant Art of Giving and Receiving Feedback
Michael E. DeBakey Department of Surgery Grand Rounds
November 4, 2020

Global Surgery Education, Ethics, and the Surgical Trainee
Michael E. DeBakey Department of Surgery Grand Rounds
November 18, 2020

Resident Presentations - December 2020
Michael E. DeBakey Department of Surgery Grand Rounds
December 2, 2020

2020: Annus Horribilis, or Annus Mirabilis?
Michael E. DeBakey Department of Surgery Grand Rounds
December 9, 2020

Professional Statement

Dr. Todd K. Rosengart, Chair and DeBakey-Bard Chair of Surgery, is a National Institutes of Health (NIH)-supported scientist with uninterrupted extramural funding since 1998. An extensively published investigator, he is also editor of Seminars in Thoracic and Cardiovascular Surgery and immediate past chair of the NIH Bioengineering, Technology, and Surgical Sciences (BTSS) study section. He is also immediate past president of the Society of Surgical Chairs, representing the academic chairs of surgery in North America, and is a member of the board of directors of the American Association for Thoracic Surgery. Basic and translational research have occupied a predominant position in Dr. Rosengart's academic career beginning with his serving as a Clinical Fellow at the NIH, and continuing with appointments as an independent investigator with American Heart Association sponsored research support. Dr. Rosengart continues to run an NIH-funded laboratory with over 20 years of NIH support in the fields of angiogenesis and cellular reprogramming. This effort has been highlighted by his role in the bench-to-bedside development of angiogenic therapy as a potential treatment for atherosclerotic coronary artery and vascular occlusive disease, and his lab's current, multi-year focus to study cardiac cellular reprogramming. He is PI of a cardiovascular surgery NIH T32 training grant and recipient of nearly $20 million in total research grants. He is chair of the American Heart Association Surgery Science Study Section, and a member of the Scientific Advisory Committee for the Leducq Foundation. Dr. Rosengart's research includes his translation of early in vivo examinations of angiogenic growth factors beginning in the mid-1980s In 1997, he and his team at Cornell performed the world's first viral-based cardiac gene transfer procedure, part of a landmark NIH and FDA-approved first-in-man Phase I/II angiogenesis trial using vascular endothelial growth factor (VEGF) to treat “no option” patients with end stage coronary artery disease. His current NIH-funded research is exploring the use of cardiogenic reprogramming transcription factors to induce in situ “cardio-differentiation” of myocardial scar fibroblasts as a myocardial regeneration strategy for the treatment of myocardial infarction. These current investigations of cellular reprogramming offer the exciting possibility of “bio-interventions” for the treatment of hundreds of thousands with advanced heart disease still not treatable by conventional therapies. Dr. Rosengart's institutional roles include his serving as chair of the BCM Faculty Group Practice Board of Governors, and as a member of the Baylor St. Luke's Medical Center Board of Directors. He recently served as board chair of the Affiliated Medical Services, which represented the consortium of BCM and University of Texas faculty staffing the HarrisHealth county medical system. He also served as national chair of the cardiac surgery service line for CHI (now Common Spirit), our 140-hospital national hospital network. As a physician-entrepreneur, Dr. Rosengart was a co-founder of Vitals.com (MDx, LLC), a a leading health provider search and physician/patient interface website with over 13 million monthly visits, and is also co-founder of XyloCor Therapeutics, which holds FDA “Fast Track” designation for a current Phase I/II testing of a novel cardiac gene therapy prototype for treating patients with end stage coronary artery disease. He holds twelve patents, including those for a method of inducing angiogenesis.

Professional Achievements

Texas “Super Doctor”
Texas Monthly
Top Doctors
Houstonian Magazine
Top Doctors
Chicago Magazine
Top Doctors
New York Magazine
America's Top Doctors
Castle Connolly
Distinguished Scientist Award
Baylor St. Luke’s Medical Center

Professional Interests

Cardiothoracic Surgery
Minimally Invasive Heart Surgery
Off-pump Surgery
Coronary Artery Bypass Surgery
Minimally invasive Aortic or Mitral Repair or Replacement
Minimally Invasive Valve Surgery

Professional Specialties

Minimally Invasive Cardiac Surgery
Minimally Invasive Valve Surgery
Adult Cardiac Surgery
Cardiothoracic Surgery
Vascular Surgery